Stock Earnings
A company insider recently sold 10,000 shares of Halozyme Therapeutics Inc. [HALO]. Should You Sale?
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Halozyme Therapeutics Inc.’s recent filing unveils that its SVP, CHIEF TECHNICAL OFFICER LaBarre Michael J. unloaded Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Halozyme Therapeutics Inc.’s recent filing unveils that its SVP, CHIEF TECHNICAL OFFICER LaBarre Michael J. unloaded Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Halozyme Therapeutics Inc.’s filing revealed that its SVP, CHIEF TECHNICAL OFFICER LaBarre Michael J. unloaded Company’s shares for reported $0.38
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Halozyme Therapeutics
Halozyme Therapeutics Inc.’s recently made public that its SVP, CHIEF TECHNICAL OFFICER LaBarre Michael J. unloaded Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Halozyme Therapeutics Inc.’s recently made public that its SVP, CHIEF TECHNICAL OFFICER LaBarre Michael J. unloaded Company’s shares for reported